Lucian Lozonschi, M.D., is professor of surgery in the Division of Cardiothoracic Surgery and the director of Surgical Heart Failure and Cardiac Transplantation. Previously, Dr. Lozonschi served as surgical director of heart transplantation at the University of Wisconsin in Madison for over six years. Dr. Lozonschi performed the first combined heart-liver transplantation in Wisconsin. He was chief of cardiac surgery at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin, which became one of the three VA hospitals in the U.S. that were approved for in-house implantation of left ventricular assist devices. In 2017, he was the first surgeon in the U.S. to implant the latest Heartmate 3 device in the veteran population.
Dr Lozonschi has a long-standing interest in robotic-assisted minimally invasive coronary bypass surgery and is the PI in the NIH sponsored robotic/hybrid coronary revascularization trial. He has been the co-PI for all TAVR trials in Wisconsin and he helped develop the Tendyne valve, a transcatheter mitral valve replacement system he invented and patented in Kiel, Germany. This led him to become the surgical proctor for the first human implants with a transcatheter mitral valve in the world, in Sydney and Brisbane, Australia, as well as in the U.S. at Abbott Northwestern Hospital in Minneapolis, Medstar Hospital in Washington, D.C., and the Cleveland Clinic in Ohio.
Dr. Lozonschi received his medical degree from G.T. Popa University of Medicine and Pharmacy, Iasi, Romania. He completed a general surgery internship at Mount Sinai School of Medicine, New York, general surgery residency at Albert Einstein College of Medicine, Montefiore Hospital, New York, and a cardiothoracic surgery fellowship at Ohio State University in Columbus, Ohio.